Patents by Inventor Ruth Navon

Ruth Navon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enzyme replacement therapy for treating lysosomal storage diseases
    Patent number: 10265412
    Abstract: The present invention relates in general to the field of enzyme replacement therapy, and specifically to chimeric proteins including protein hormone-therapeutic protein conjugates and fusion proteins, wherein the protein hormone is selected from a protein hormone which is able to cross the blood brain barrier, for the treatment of lysosomal storage diseases, compositions of the same and to methods of use thereof.
    Type: Grant
    Filed: February 6, 2007
    Date of Patent: April 23, 2019
    Assignees: Ramot at Tel-Aviv University Ltd., Yeda Research and Development Co. Ltd. at the Weizmann Institute of Science, The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical Center
    Inventors: Naftali Stern, Ruth Navon, Anthony Futerman, Ari Zimran, Etty Osher
  • ENZYME REPLACEMENT THERAPY FOR TREATING LYSOSOMAL STORAGE DISEASES
    Publication number: 20100183577
    Abstract: The present invention relates in general to the field of enzyme replacement therapy, and specifically to chimeric proteins including protein hormone-therapeutic protein conjugates and fusion proteins, wherein the protein hormone is selected from a protein hormone which is able to cross the blood brain barrier, for the treatment of lysosomal storage diseases, compositions of the same and to methods of use thereof.
    Type: Application
    Filed: February 6, 2007
    Publication date: July 22, 2010
    Inventors: Naftali Stern, Ruth Navon, Anthony Futerman, Ari Zimran, Etty Osher
  • Novel mutations in hexosaminidase A
    Publication number: 20070218469
    Abstract: The present invention discloses methods and compositions for detecting novel mutations in the ? chain of the hexosaminidase gene. These methods facilitate rapid screening for Tay-Sachs disease carriers, especially in the Ashkenazi Jewish population. The novel mutations include the single nucleotide substitutions 638A>C and 181C>T.
    Type: Application
    Filed: October 3, 2006
    Publication date: September 20, 2007
    Inventor: Ruth Navon